Fidelity Investments’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-61
| Closed | -$271 | – | 5482 |
|
2024
Q1 | $271 | Buy |
+61
| New | +$271 | ﹤0.01% | 4892 |
|
2023
Q4 | – | Sell |
-5
| Closed | -$36 | – | 5520 |
|
2023
Q3 | $36 | Sell |
5
-763
| -99% | -$5.49K | ﹤0.01% | 4985 |
|
2023
Q2 | $7.19K | Sell |
768
-928
| -55% | -$8.68K | ﹤0.01% | 4254 |
|
2023
Q1 | $28K | Hold |
1,696
| – | – | ﹤0.01% | 3692 |
|
2022
Q4 | $45.5K | Sell |
1,696
-29
| -2% | -$778 | ﹤0.01% | 3473 |
|
2022
Q3 | $91K | Sell |
1,725
-116
| -6% | -$6.12K | ﹤0.01% | 3288 |
|
2022
Q2 | $165K | Buy |
1,841
+129
| +8% | +$11.6K | ﹤0.01% | 3173 |
|
2022
Q1 | $148K | Buy |
+1,712
| New | +$148K | ﹤0.01% | 3324 |
|
2021
Q4 | – | Sell |
-4
| Closed | -$1K | – | 4598 |
|
2021
Q3 | $1K | Buy |
4
+3
| +300% | +$750 | ﹤0.01% | 4142 |
|
2021
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4506 |
|